EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Lumiera Health's enterprise value is C$2.52 Mil.
Lumiera Health's EBITDA for the trailing twelve months (TTM) ended in Aug. 2023 was C$-1.27 Mil. Therefore, Lumiera Health's EV-to-EBITDA for today is -1.98.
The historical rank and industry rank for Lumiera Health's EV-to-EBITDA or its related term are showing as below:
TSXV:NHP.H'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -67.76 Med: -2.43 Max: 4.89
Current: -1.98
During the past 10 years, the highest EV-to-EBITDA of Lumiera Health was 4.89. The lowest was -67.76. And the median was -2.43.
TSXV:NHP.H's EV-to-EBITDA is not ranked
in the Drug Manufacturers industry.
Industry Median: 14.265
vs TSXV:NHP.H: -1.98
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Lumiera Health EV-to-EBITDA Historical Data
The historical data trend for Lumiera Health's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Lumiera Health's EV-to-EBITDA
For the Drug Manufacturers - Specialty & Generic subindustry, Lumiera Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lumiera Health's EV-to-EBITDA Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Lumiera Health's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Lumiera Health's EV-to-EBITDA falls into.
Lumiera Health EV-to-EBITDA Calculation
Lumiera Health's EV-to-EBITDA for today is calculated as:
Lumiera Health's current Enterprise Value is C$2.52 Mil.
Lumiera Health's EBITDA for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.27 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lumiera Health (TSXV:NHP.H) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Lumiera Health's PE Ratio for today is calculated as:
Lumiera Health's share price for today is C$0.005.
Lumiera Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.010.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Lumiera Health's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Lumiera Health Inc is a natural health products company. The company is developing products focusing on the endocannabinoid system and providing treatments for chronic pain and inflammation.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSXV:NHP.H has been successfully added to your 